Filing Details

Accession Number:
0001104659-23-061819
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-17 16:05:15
Reporting Period:
2023-05-15
Accepted Time:
2023-05-17 16:05:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH Pharmaceutical Preparations (2834) 330702205
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866024 Gayle Deflin C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-15 1,500 $43.15 8,682 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.149 to $43.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.